About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical firm at the forefront of revolutionizing treatments for central nervous system (CNS) disorders. We are dedicated to bridging critical gaps in patient care by developing innovative therapies that focus on novel mechanisms of action to significantly enhance patient outcomes. Our cutting-edge neuroscience portfolio features FDA-approved solutions for major depressive disorder, excessive daytime sleepiness due to narcolepsy, obstructive sleep apnea-related symptoms, and migraines. Additionally, we are advancing multiple late-stage programs addressing a wide range of severe neurological and psychiatric disorders that affect over 150 million individuals in the United States. Together, we are committed to tackling the most pressing challenges in brain health, enabling patients and their families to thrive. To learn more, visit us at www.axsome.com and connect with us on LinkedIn.

